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1. Introduction  
Recently, chronic inflammation induced by infection has been postulated to be an important 
risk factor of various cancers (Schetter et al., 2010; Aggarwal & Sung, 2011; Kamp et al., 2011; 
Rook & Dalgleish, 2011; Trinchieri, 2011). Many malignancies arise from areas of infection 
and inflammation (Balkwill & Mantovani, 2001; Coussens & Werb, 2002). Epidemiological 
and experimental studies have provided evidence showing that chronic infection and 
inflammation contribute to a substantial part of environmental carcinogenesis (Coussens & 
Werb, 2002; IARC, 2003). It has been estimated that chronic inflammation accounts for 
approximately 25 % of human cancers (Hussain S. P. & Harris, 2007). International Agency 
for Research on Cancer (IARC) has estimated that infectious diseases account for 
approximately 18 % of cancer cases worldwide (IARC, 2003). During inflammation, nitric 
oxide (NO) and reactive oxygen species (ROS) are generated from inflammatory cells and 
considered to play the key role in carcinogenes (Hofseth et al., 2003a; Hofseth et al., 2003b; 
Hussain S. P. et al., 2003; Ohshima et al., 2003). Inducible nitric oxide synthase (iNOS) 
catalyzes the production of NO particularly during inflammation, leading to generation of 
various reactive nitrogen species (RNS), such as NOx and peroxynitrite (ONOO-). RNS 
generated during infection with influenza viruses can mediate the formation of 8-
nitroguanine, a nitrative lesion of nucleic acids, via ONOO- formation (Maeda H. & Akaike, 
1998; Akaike et al., 2003). 8-Nitroguanine formed in DNA is chemically unstable, and thus 
can be spontaneously released, resulting in the formation of an apurinic site (Yermilov et al., 
1995a). The apurinic site can form a pair with adenine during DNA synthesis, leading to 
G:C-to-T:A transversions (Kawanishi & Hiraku, 2006) (Fig. 1). Thus, 8-nitroguanine is a 
potentially mutagenic DNA lesion, which can participate in initiation and promotion in the 
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infection-related carcinogenesis (Loeb & Preston, 1986; Kawanishi et al., 2006). Our studies 
have demonstrated that 8-nitroguanine is formed at the sites of carcinogenesis in humans 
and experimental animals (Ma et al., 2004; Pinlaor et al., 2004b; Ding et al., 2005; Horiike et 
al., 2005; Ma et al., 2006; Hoki et al., 2007a; Hoki et al., 2007b; Fujita et al., 2008; Ma et al., 
2008; Tanaka et al., 2008; Ma et al., 2009; Ma et al., 2010). Moreover, our studies have 
demonstrated that 8-nitroguanine was formed in Oct3/4-positve stem cells in S. 
haematobium-associated cystitis and cancer tissues. Inflammation by S. haematobium infection 
may increase the number of mutant stem cells, in which iNOS-dependent DNA damage 
occures via NF-B activation leading to tumor development (Ma et al., 2011). 
We describe the procedures of these experiments including the 8-nitroguanine antibody 
produce method, and employed this rabbit anti-8-nitroguanine polyclonal antibody to 
examine the formation and localization of 8-nitroguanine in patients and animals with 
inflammation related carcinogenesis by the immunohistochemical method in our laboratory. 
These protocols provide a detailed description of methodologies successfully used to define 
the pattern of 8-nitroguanine expression in pathological samples. Visualization of nuclear 8-
nitroguanine expression aids in assessment of potential sites of nitrative DNA damage 
within inflammation-related carcinogenesis. On the basis of our results, we propose that 8-
nitroguanine is a promising biomarker to evaluate the potential risk of inflammation-
mediated carcinogenesis. 
 
Fig. 1. Formation of 8-nitroguanine during chronic inflammation and proposed mechanism 
of mutation. 
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2. Immunohistochemical identification of 8-nitroguanine 
2.1 Production of anti-8-nitroguanine antibody 
Anti-8-nitroguanine polyclonal antibody was produced by a modified method (Akaike et 
al., 2003). 8-Nitroguanosine was incubated with sodium metaperiodate for 20 min at room 
temperature and then conjugated with rabbit serum albumin (RSA) for 1 h followed by 
incubation with sodium borohydride for 1 h. The conjugate was dialyzed against 150 mM 
NaCl overnight. 8-Nitroguanine–aldehyde–RSA conjugate mixed with Freund’s complete 
adjuvant was injected in rabbit by intracutaneous administration. After 4 weeks of the 
immunization, the same antigen was given and the blood was taken two weeks later. We 
immobilized 8-nitroguanine in a cellulofine GCL-2000m column (Seikagaku Kogyo, Tokyo, 
Japan), and then purified the antibody by affinity chromatography. 
2.2 Specificity of anti-8-nitroguanine antibody 
Specificity of the purified antibody was examined by a dot immunobinding assay and 
absorption test (Pinlaor et al., 2004a). Purified antibody gave a strong immunostaining only 
on the spot of 8-nitroguanine conjugate (Fig. 2A). The immunoreactivity disappeared only 
when the antibody was pre-incubated with 8-nitroguanine. In contrast, immunoreactivity 
with 8-nitroguanine conjugate did not disappear when the antibody was preincubated with 
3-nitrotyrosine, guanosine, 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG), 
deoxyguanosine, 8-bromoguanosine, and xanthosine (Fig. 2B). 
 
 
Fig. 2. Dot immunobinding assay and absorption test of anti-8-nitroguanine antibody.  
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Antigen–antibody reactions were visualized by the peroxidase-anti-peroxidase method. 
Purified antibody gave a strong immunostaining only on the spot of 8-nitroguanine 
conjugate (A). 8-Nitroguanine, 3-nitrotyrosine, guanosine, 8-oxodG and deoxyguanosine 
were incubated with the antibody at the concentration of 0.7 g/ml, and were applied to 8-
nitroguanine conjugate. Immunoreactivity disappeared only when the antibody was 
pretreated with 8-nitroguanine (B). 8-NG, 8-nitroguanine; 3-NT, 3-nitrotyrosine; G, 
guanosine; dG, deoxyguanosine and 8-BromoG, 8-bromoguanosine. 
2.3 Materials and animals 
2.3.1 Donor tissue source 
Rat, mouse, hamster, served as the donor tissue source in accordance with the guidelines 
Proper Care and Use of Laboratory Animals in Research. For the patient‘s operation 
samples, written informed consent was obtained from each patient, and the study protocol 
followed the ethical guidelines of the Declaration of Helsinki.  
2.3.2 Chemicals and reagents for immunohistochemistry (IHC) and special equipment 
Silanized slides (Dako, Japan) 
Dapi-Fluoromount-GTM Mounting Medium (Southern Biotech, Birmingham, USA) 
Malinol mounting medium (Muto Pure Chemicals Co. Tokyo,Japan) 
3,3’-Diaminobenzidine tetrahydrochloride dehydrate (DAB) (Dojindo, Kumamoto, Japan) 
Goat anti-rabbit -globulin-HRP (Medical Laboratories, Nagoya, Japan) 
Normal goat serum (Medical Laboratories, Nagoya, Japan) 
DifcoTM Skim milk (Becton, Dickinson and Company, Sparks, USA) 
Rabbit anti-8-nitroguanine antibody (Made by Ma N. et al, Suzuka University of Medical 
Science, Japan) 
Anti-8-hydorxy-2’-deoxyguanosine monoclonal antibody (Japan Institute for the Control of 
Aging, Shizuoka, Japan) 
Rabbit peroxidase-anti-peroxidase (PAP) (ab28054, abcam, Tokyo, Japan) 
Alexa 488-labeled goat antibody against mouse IgG (Molecular Probes Inc., Eugene, Oregon, 
USA) 
Alexa 594-labeled goat antibody against rabbit IgG (Molecular Probes Inc., Eugene, Oregon, 
USA) 
Other antibodies from abcam or Santa Cruz Biotechnology, Inc. USA.  
Tris-HCl (Sigma, St. Louis, MO, USA) 
Sodium chloride (Nacalai, Kyoto, Japan) 
Sodium pentobarbital (Nacalai, Kyoto, Japan) 
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Ethanol (Nacalai, Kyoto, Japan) 
Xylene (Nacalai, Kyoto, Japan)  
Paraformaldehyde (Nacalai, Kyoto, Japan) 
Monobasic and dibasic salts of sodium and potassium phosphate (Nacalai, Kyoto, Japan) 
Confocal laser scanning microscopy (FV-1000D, Olympus, Tokyo, Japan) 
Fluorescent light microscope (BX53, Olympus, Tokyo, Japan) 
Sliding microtome (RM2265, Leica, Germany) 
2.4 Detailed procedure for IHC 
2.4.1 Time required for immunohistochemistry of 8-nitroguanine 
Average time for immunohistochemical (IHC) localization of 8-nitroguanine is 2-3 days, not 
including preparation and mounting of tissues. Albeit, time varies with duration of 
antibody incubation of second antibody in double fluorescent immunohistochemistry. 
2.4.2 Preparation of animal tissues for IHC 
1. Animal is weighed and anesthetized by intraperitoneal injection of 50 mg/kg sodium 
pentobarbital. 
2. After the animal has fallen asleep, firmly pinch the foot with a pair of tweezers. If there 
is no response, then proceed with the surgery. 
3. Position the animal on its back. Open the abdominal cavity with a midline incision to 
the sternum. Make a diagonal cut to each side of the sternum through the rib cage 
extending to either side of the neck. Care should be taken not to sever any vessels or 
puncture the heart. The sternum may now be clamped back with hemostatic forceps to 
give access to the heart. 
4. Cut the connective tissue surrounding the diaphragm and make a lateral cut on each 
side of the animal to allow proper drainage of perfusate. 
5. Lift the lungs to expose the descending aorta and occlude the vessel using hemostatic 
forceps. 
6. Make a small incision in the right atrium. 
7. Insert an i.v. catheter into the left ventricle. Remove the needle from the catheter. 
Position so that the tip of the catheter resides within the aortic arch. The optimal size of 
the catheter for transcardial perfusion is 18 and 22 gauge for rat and mouse, 
respectively. 
8. Connect the catheter to the perfusion apparatus and begin the flow of 0.9% NaCl into 
the animal. For an adult rat 80 ml 0.9% saline should be infused over 3 min. For a 
mouse 20 ml saline should be infused over 2 min. Progress of the perfusion may be 
monitored by assessment of the eyes and gums which should be blanched toward the 
end of this step. 
9. Switch perfusion to 0.1 M phosphate buffer (PB) containing 4% paraformaldehyde. It is 
common to see turgor and twitching of the upper extremities at the initial flow of 
fixative into the animal. Perfuse an adult rat, 300 ml of fixative over 10 min should be 
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used. For a mouse approximately 80 ml over 5 min of fixative should be infused. After 
completion of the procedure, the arms and tip of the nose should be stiff. 
10. Disconnect the rat or mouse from the perfusion apparatus and carefully remove the 
organ to avoid damage to the tissue. After carefully removing organ from the body, 
continue fixation of adult tissue at room temperature for 3 h. 
11. Following incubation, tissue for IHC should be paraffin-embedded and then sectioned 
at 5m thickness onto silanized glass slides. Slides may be stored at ambient 
temperature in slide cases until use. 
2.4.3 Detailed procedure for IHC staining 
Step A. Immunofluorescent staining procedure 
1. Paraffin sections of human or animal tissues are deparaffinized in xylene for 3 min with 
frequent shaking in a glass box. Then, the sections are treated in xylene in another glass 
box for 3 min, followed by the treatment with 100, 90, 80, 70, and 50% (v/v) ethanol for 
30–60 sec. To insure complete removal of paraffin, soak sections in PBS for 30 min. 
2. To retrieve the antigens, the sections are heated in 5% (w/v) urea for 5 min in a 
microwave oven, and then left sections on the 5% urea until the temperature reducing 
to room temperature. 
3. Rinse sections in PBS at room temperature, 3 times for 5 min each. 
4. Block sections by 30 min incubation in PBS containing 5% (v/v) normal goat serum 
antibody buffer, or 5% (w/v) skim milk. 
5. The sections are incubated with the primary antibody, rabbit polyclonal anti-8-
nitroguanine antibody (1–2g/ml), overnight at room temperature. When double 
immunofluorescence labeling study is performed, mouse monoclonal antibody is mixed 
with anti-8-nitroguanine antibody and the sections are treated with this mixture. Note: 
the final concentration of antibody depends on the specific antibody preparation being 
used and may need to be empirically determined. 
6. The sections are washed with PBS at room temperature, 3 times for 5 min each. 
7. The sections are incubated with the secondary antibody, Alexa 594-labeled goat 
antibody against rabbit IgG (1:400) for 3 h at room temperature. When double 
immunofluorescence labeling study is performed, Alexa 488-labeled goat antibody 
against mouse IgG (1:400) is mixed with Alexa 594-labeled goat antibody against rabbit 
IgG and the sections are treated with this mixture. Note: if primary serum is derived 
from a source other than rabbit, then the choice of secondary antibody should be 
adjusted accordingly for specificity. 
8. Wash sections with PBS 3 times over 30 min. 
9. Pipet Dapi-Fluoromount-GTM Mounting Medium onto the section and then cover with a 
cover glass. Dry overnight covered at 4°C on a refrigerator. 
10. The stained sections are examined under a fluorescent microscope. 
Step B. Peroxidase anti-peroxidase immunohistochemical method 
1. Deparaffinize as Step A (1) 
2. To retrieve the antigens as Step A (2). 
3. Rinse sections in PBS at room temperature, 3 times for 5 min each. 
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4. The sections are incubated with 3% H2O2 for 30 min, and rinse sections in PBS for 10 
min at room temperature. 
5. Block sections by 30 min incubation in PBS containing 5% (v/v) normal goat serum or 
5% (w/v) skim milk. 
6. The sections are incubated with the primary antibody, rabbit polyclonal anti-8-
nitroguanine antibody (1–2 g/ml), overnight at room temperature. 
7. Wash sections in PBS at room temperature, 3 times for 5 min each. 
8. The sections are incubated with goat anti-rabbit IgG antibody (1:200) for 3h at room 
temperature, fellow by wash in PBS, 3 times for 5 min each. 
9. The sections are incubated with peroxidase anti-peroxidase complex (PAP, 1:200) for 2h 
at room temperature, fellow by wash in PBS, 3 times for 5 min each. 
10. Equilibrate sections in 0.05 M Tris, pH 7.5 with two washes for 10 min each. 
11. Incubate sections in DAB/Tris solution 10 mg 3,3-diaminobenzidine tetrahydrochloride 
dihydrate in 100 ml 0.05 M Tris, pH 7.4; filter under a hood with general usage filter 
paper. Incubate sections in developer for up to 15 min. Check sections frequently under 
a microscope for the degree of development, and reaction product is brown. 
12. Terminate reaction by washing sections 3 times for 10 min each in 0.05 M Tris, pH 7.4. 
13. Wash sections 2 times for 5 min in distilled water (DW). 
14. Counterstain sections with Mayer hematoxylin for 1-1.5 min if necessary. 
15. Wash sections 2 times for 5 min in DW. 
16. Dehydrate sections in Coplin jars containing graded ethanol 50–80%, 3 min each; twice 
in 95% ethanol 3 min each; and 3 times in 100% ethanol 3 min each. Tissue is cleared by 
incubation 3 times for 5 min each in xylene, and coverslipped using Maninol mounting 
medium. 
Step C. Pre-absorption immunostaining 
To prepare pre-absorbed 8-nitroguanine antibody place equal amounts of 8-nitroguanine 
antibody in 1.5 ml Eppendorf microfuge tubes. For the primary antibody to be pre-absorbed 
pure 8-nitroguanine is added to give a final protein concentration greater than 1 g/ml. An 
equal amount of diluents without 8-nitroguanine is added to the control antiserum. 
Mixtures are incubated for 2 h at room temperature and then diluted to their final working 
concentration with antibody buffer. Pre-absorption is then continued by incubation 
overnight at 4°C prior to use. Control and pre-absorbed antibody are used in parallel at 
StepA or StepB. Proceed as StepA (1) through (10). 
3. 8-Nitroguanine accumulation in inflammation-related cancer 
3.1 Application of Immunochemistry employing anti-8-nitroguanine antibody 
We have performed immunohistochemical analysis for 8-nitroguanine formation in various 
clinical specimens and animal models of inflammation-related carcinogenesis. We have 
firstly demonstrated that 8-nitroguanine is formed at the sites of carcinogenesis regardless of 
etiology, and we have proposed the possibility that 8-nitroguanine is a potential biomarker 
to evaluate the risk of inflammation-associated carcinogenesis (Kawanishi & Hiraku, 2006; 
Kawanishi et al., 2006). In clinical specimens, 8-nitroguanine was formed in the gastric 
grand epithelial cells of patients with gastritis caused by Helicobacter pylori (H. pylori) 
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infection (Ma et al., 2004), hepatocytes of patients with chronic hepatitis C (Horiike et al., 
2005), oral precancerous lesions oral lichen planus (OLP) (Chaiyarit et al., 2005) and oral 
leukoplakia (Ma et al., 2006), soft tissue sarcoma (Hoki et al., 2007a; Hoki et al., 2007b) and 
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) (Ma et al., 2008). 
In animal models, 8-nitroguanine was formed in a mouse model of inflammatory bowel 
disease (IBD) (Ding et al., 2005). 8-Nitroguanine was formed in the bile duct epithelium of 
the liver of hamsters infected with the liver fluke, Opisthorchis viverrini, which causes cancer 
of intrahepatic bile duct (Pinlaor et al., 2003; Pinlaor et al., 2004a). The treatment with 
praziquantel, an antiparasitic drug, reduced 8-nitroguanine formation (Pinlaor et al., 2006). 
3.1.1 H.pylori gastritis and eradication treatment 
H. pylori infection, which is the major cause of atrophic gastritis, is a high risk factor for 
gastric carcinoma (Peek & Blaser, 2002). Lipopolysacharide (LPS), a component of Gram-
negative bacteria such as H. pylori, is a TLR4 ligand that induces inflammatory responses via 
NF-B expression (Maeda S. et al., 2001). NF-B, which is involved in the regulation of 
iNOS, had been reported to function as a tumor promoter in inflammation-associated cancer 
(Surh et al., 2001; Pikarsky et al., 2004). In patients with H.pyroli-induced gastritis or gastric 
ulcers, iNOS is expressed in the infiltrating inflammatory cells (Mannick et al., 1996). ROS 
and RNS generated by inflammatory cells may contribute to carcinogenesis through the 
formation of DNA base lesions, such as 8-oxodG, which can lead to a G:C-to-T:A 
transversion (Shibutani et al., 1991; Kawanishi & Murata, 2006). 8-oxodG, a marker of 
oxidative DNA damage, is found at a significantly increased level in the gastric epithelium 
of H. pylori-infected patients (Baik et al., 1996; Pignatelli et al., 2001). Therefore, in addition 
to 8-oxodG formation, the accumulation of 8-nitroguanine may play a key role in the 
initiation and/or promotion of inflammation-mediated carcinogenesis. To evaluate whether 
nitrative DNA damage plays a role early in the carcinogenic process triggered by H. pylori 
and the affection of H. pylori eradication treatment on 8-nitroguanine formation, we used a 
double-immunofluorescence staining procedure to compare the formation of both 8-
nitroguanine and 8-oxodG in the gastric epithelium of gastritis patients with and without H. 
pylori infection, and before and after H. pylori eradication treatment patients.  
The formation of 8-nitroguanine and 8-oxodG in gastric epithelium in gastritis patients with 
H. pylori infection is shown in Fig. 3. Notably, intense immunoreactivity of both lesions was 
observed to co-localize in gastric gland epithelial cells in patients with H. pylori infection 
(Fig. 3, HP(+)). On the other hand, in gastritis patients without H. pylori infection, little or no 
immunoreactivity was observed in gastric gland epithelial cells (Fig. 3, HP(-)). 8-
Nitroguanine formation was observed in both the nuclei and the cytoplasm of the labeled 
epithelial cells, suggesting that it can form in both DNA and RNA. The 8-oxodG 
immunoreactivity was coincident with that of 8-nitroguanine within the nuclei of gastric 
gland cells and surface epithelial cells in H. pylori-infected patients (Fig. 3, merged labeling 
in yellow). Regardless of the H. pylori infection status, immunoreactivity of 8-nitroguanine 
and 8-oxodG was observed in inflammatory cells. 
Moreover, we found that 8-nitroguanine formation in patients with H. pylori infection was 
dramatically decreased by eradication. After eradication, reduction of 8-nitroguanine and 8-
oxodG formation in the epithelia was observed in 58% and 53% patients, respectively (Fig. 
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4A, B). Despite the complete eradication of H. pylori, reduced 8-nitroguanine and 8-oxodG 
production by infiltrating inflammatory cells were found only in 26% and 36% patients, 
respectively. Mean 8-nitroguanine and 8-oxodG immunoreactivities in inflammatory cells 
was not significantly decreased after the eradication treatment. 
 
 
 
 
 
 
 
 
Fig. 3. 8-Nitroguanine and 8-oxodG formation in gastritis patients with and without H. 
pylori infection. Double immunofluorescence staining of paraffin sections shows the 
localization of 8-oxodG and 8-nitroguanine in the gastric epithelium. In H. pylori-infected 
patients (HP(+)), the immunoreactivity of 8-nitroguanine and 8-oxodG co-localizes 
primarily in the nuclei of gastric gland epithelial cells and in some inflammatory cells in the 
corpus (Merged). In chronic gastritis patients without H. pylori-infection (HP(-)), the 
immunoreactivity of 8-nitroguanine and 8-oxodG is observed mainly in the inflammatory 
cells, while the gastric gland epithelial cells displayed little or no immunoreactivity. Scale 
bar represents 50 m. 
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Fig. 4. Detective 8-nitroguanine and 8-oxodG formation in the H. pylori eradication patients 
by double immunofluorescent method (A) and peroxidase anti-peroxidase 
immunohistochemical method (B). Positive immunoreactivity for 8-nitroguanine was 
predominantly localized in the nuclei and cytosol of foveolar cells, neutrophils and 
lymphocytes. The immunoreactivity of 8-nitroguanine and 8-oxodG on the nuclei of 
foveolar cells was greater reduced after successful H. pylori eradication. Conversely, reduced 
8-nitroguanine and 8-oxodG formation in infiltrating inflammatory cells did not 
significantly decrease after the treatment. Scale bar represents 50 m. 
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The mechanisms by which H. pylori infection causes gastric cancer have been investigated. 
LPS, a component of Gram-negative bacteria, including H. pylori, is a ligand of TLR4. TLR4 
is involved in activation of the transcription factor NF-B (Maeda H. & Akaike, 1998), which 
mediates expression of iNOS and various inflammatory cytokines. Alternatively, the Cag-
positive H.pylori strain induces an intense inflammatory response, including interleukin-8 
(IL-8) production by epithelial cells and subsequent production of tumor necrosis factor 
(TNF-)by inflammatory cells (Peek & Blaser, 2002). The host immune response to H. pylori 
mediated by cytokines, resulting in iNOS expression, may lead to an increase in the 
accumulation of 8-nitroguanine and 8-oxodG in gastric epithelium. 
3.1.2 Leukoplakia, oral lichen planus and oral cancer 
More than 300,000 new cases are being diagnosed with oral squamous cell carcinoma 
annually in the world (Sudbo & Reith, 2005). Oral leukoplakia is a precancerous lesion 
characterized by white plaque and hyperkeratosis (Neville & Day, 2002; Reibel, 2003). Five 
to 15% of leukoplakia is histologically classified as dysplasia (Suarez et al., 1998; Sudbo & 
Reith, 2005). The presence of epithelial dysplasia may be important in predicting malignant 
development. A substantial part of dysplasia is reported to develop into oral carcinoma 
(Lumerman et al., 1995; Sudbo & Reith, 2005). Oral lichen planus (OLP) is a chronic 
inflammatory mucosal disease (Scully et al., 1998). Several pathological features indicate 
that OLP is an immunologically mediated inflammatory response, including an intense, 
band-like infiltrate of predominantly T-lymphocytes subjacent to epithelium. Basal 
epithelial cells are the target for immune destruction by cytotoxic T-lymphocytes (Tyldesley 
& Appleton, 1973; Dekker et al., 1997). The most important complication of OLP is 
development of oral squamous cell carcinoma (OSCC) (Rajentheran et al., 1999; Mignogna et 
al., 2004). 
Antioxidants have induced regression of precancerous oral lesions including leukoplakia 
(Enwonwu & Meeks, 1995), suggesting that ROS are involved in the pathogenesis of 
precancerous lesions. ROS are considered to participate in carcinogenesis by forming 
oxidative DNA lesions, such as 8-oxodG (Kawanishi et al., 2001; Kawanishi et al., 2002). 
A chronic inflammatory infiltration was generally present in oral tissues of leukoplakia 
patients (Rodriguez-Perez & Banoczy, 1982). Expression of COX-2, an inflammatory 
mediator, was increased in oral mucosa with various lesions of leukoplakia, including 
hyperplasia and dysplasia (Renkonen et al., 2002; Altorki et al., 2004). These reports 
implicate that inflammation may mediate the development of oral cancer from leukoplakia. 
Therefore, we examined whether nitrative stress contributes to the development of oral 
carcinogenesis from leukoplakia through DNA damage. 
We demonstrated that accumulation of 8-nitroguanine and 8-oxodG was observed in oral 
epithelium of biopsy specimens from patients with OLP and OSCC, whereas no 
immunoreactivity was observed in normal oral mucosa (Chaiyarit et al., 2005). 8-
Nitroguanine and 8-oxodG were also observed in oral epithelium of patients with 
leukoplakia (Ma et al., 2006). Co-localization of 8-nitroguanine and iNOS was found in oral 
epithelium of patients with OLP, OSCC and leukoplakia. Immunoreactivity of 3-
nitrotyrosine, which is formed by protein tyrosine nitration and considered to be a 
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biochemical marker for inflammation, was also observed in oral epithelial cells. 
Accumulation of p53 was observed in oral epithelium in OLP and leukoplakia, and more 
prominent expression of this protein was observed in OSCC patients. Our findings 
demonstrate that iNOS-dependent DNA damage may lead to p53 accumulation not only in 
OLP and leukoplakia, but also in OSCC. It is concluded that the formation of 8-nitroguanine 
and 8-oxodG may contribute to the development of oral cancer from OLP and leukoplakia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Localization of 8-nitroguanine and 8-oxodG and histopathological changes in oral 
tissues of leukoplakia patients. Paraffin sections were immunostained with anti-8-
nitroguanine antibody and anti-8-oxodG antibody using double immunofluorescence 
technique as described in immunofluorescent staining procedure procedures. Strong 8-
nitroguanine and 8-oxodG immunoreactivities are observed in the nucleus of the same 
epithelial cells in supra-basal and basal layers and epithelial-connective tissue interface area 
of leukoplakia patients. The distribution of 8-nitroguanine- and 8-oxodG-positive cells is 
similar to that of dysplastic epithelial cells. Little or no immunoreactivity of 8-nitroguanine 
and 8-oxodG was observed in normal mucosa. Scale bar represents 50 m. 
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Fig. 6. Localization of 8-nitroguanine, PCNA, p53, iNOS and 3-nitrotyrosine in oral tissues 
of leukoplakia patients. Paraffin sections were immunostained with anti-8-nitroguanine 
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antibody and anti-PCNA or anti-3-nitrotyrosine or anti-iNOS, p53 antibody using double 
immunofluorescence technique. 8-Nitroguanine formation is observed mainly in the nucleus 
of oral epithelial cells. Strong expression of PCNA and p53 was observed in the nucleus of 8-
nitroguanine-positive cells in the basal layer. iNOS expression is strongly observed in 
inflammatory cells and weakly in the cytoplasm of epithelial cells. Moreover, strong 8-
nitroguanine and 3-nitrotyrosine immunoreactivities are observed in the nucleus of the 
same epithelial cells. Scale bar represents 50 m. 
3.1.3 Epstein-Barr virus and nasopharyngeal carcinoma 
NPC is a human epithelial tumor with a high prevalence in the southern Chinese 
population. In southern China, the incidence rate is about 25–50 per 100,000 person-year and 
100-fold higher than that in the Western world. In contrast to other head cancer and 
epithelial malignancy in general, a unique feature of NPC is its strong association with 
Epstein-Barr virus (EBV) (McDermott et al., 2001). Various transcription factors are known 
to participate in iNOS expression including signal transducers and activators of 
transcription (STATs), such as STAT1 and STAT3 (Tedeschi et al., 2003; Lo et al., 2005). 
Epidermal growth factor receptor (EGFR) physically interacts with STAT3 in the nucleus, 
leading to transcriptional activation of iNOS (Lo et al., 2005). STAT3 is repeatedly activated 
through phosphorylation via the expression of latent membrane protein 1 (LMP1) as well as 
EGFR (Chen et al., 2003; Tao et al., 2005), and interleukin-6 (IL-6) is required for  
LMP1-mediated STAT3 activation (Chen et al., 2003). In addition, LMP1-mediated  
iNOS expression was reported in EBV-infected epithelium cell lines, which play a role in 
colonization independent of anchorage and tumorigenicity in nude mice (Yu et al.,  
2002). We performed double immunofluorescent staining method to examine the formation 
of DNA lesions, 8-nitroguanine and 8-oxodG in surgical and biopsy specimens  
of nasopharyngeal tissues from NPC patients and chronic nasopharyngitis patients.  
We also examined the expression of iNOS, STAT3, EGFR and IL-6 in these specimens  
to examine contribution of these molecules to iNOS expression for 8-nitroguanine 
formation. 
Using biopsy and surgical specimens of nasopharyngeal tissues from NPC patients in 
southern China, we performed double immunofluorescent staining to examine the 
formation of 8-nitroguanine and 8-oxodG (Ma et al., 2008; Huang et al., 2011). Intensive 
immunoreactivity of iNOS was detected in the cytoplasm of 8-nitroguanine-positive 
cancer cells. DNA lesions and iNOS expression were also observed in epithelial cells of 
EBV-positive patients with chronic nasopharyngitis but weaker than those in NPC 
patients (Fig. 7.). No or few DNA lesions were observed in EBV-negative subjects. EGFR 
and phosphorylated STAT3 were strongly expressed in cancer cells of NPC patients, 
suggesting that the STAT3-dependent mechanism is important to the carcinogenesis (Ma 
et al., 2008). IL-6 was expressed mainly in inflammatory cells of nasopharyngeal tissues of 
EBV-infected patients. We also found that serum levels of 8-oxodG were significantly 
higher in NPC patients than control subjects (Huang et al., 2011). Collectively, these 
findings indicate that the nuclear accumulation of EGFR and activation of STAT3 by IL-6 
play a key role in iNOS expression and resultant DNA damage, leading to EBV-related 
NPC.  
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Fig. 7. Formation of 8-nitroguanine and 8-oxodG and expression of LMP, iNOS, STAT3 and 
EGFR in the nasopharyngeal tissues of NPC and chronic nasopharyngitis patients.  
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8-Nitroguanine and 8-oxodG are co-localized in cancer cells. These DNA lesions are formed 
mainly in the nucleus and weakly in the cytoplasm. The formation of these DNA lesions 
was also observed in inflammatory cells in stroma in NPC patients and the epithelium in 
patients with chronic nasopharyngitis. Immunoreactivity of LMP1 is clearly observed along 
cell membrane and the cytoplasm of cancer cells. iNOS and 8-nitroguanine are colocalized in 
cancer cells of NPC patients. Expression of EGFR and STAT3 are colocalized in 
nasopharyngeal epithelical cells of EBV-positive chronic nasopharyngitis patients. Scale bar 
represents 50 m. 
3.1.4 Inflammatory bowel diseases and colon cancer 
Ulcerative colitis and Crohn’s disease are well known as chronic inflammatory diseases in 
the lower bowel, and share many clinical and pathological characteristics. These diseases are 
referred to as inflammatory bowel disease (IBD), which leads to long-term impairment of 
intestinal structure and function (Podolsky, 2002). A large number of immunological 
abnormalities have been noted in patients with IBD (Bouma & Strober, 2003). It is well 
established that an increased cancer risk occurs in tissues undergoing chronic inflammation. 
Epidemiological studies have suggested that the incidence of colorectal cancer in IBD is 
greater than the expected incidence in the general population (Ekbom et al., 1990; Langholz 
et al., 1992; Choi & Zelig, 1994; Pikarsky et al., 2004). The histological and molecular 
signatures suggest an inflammation-driven carcinogenesis process in IBD patients. To 
evaluate whether nitrative DNA damage plays a role in the carcinogenic process triggered 
by IBD, we prepared a mouse model of IBD induced by transfer of CD45RBhighCD4+ T cells 
lacking regulatory T cells to SCID mice (Powrie et al., 1993; Philippe et al., 2003), since 
mouse models of IBD can result from either excessive effector T cell function or deficient 
regulatory T cell function (Bouma & Strober, 2003). We performed a double 
immunofluorescent staining procedure to examine the formation of 8-nitroguanine and 8-
oxodG in the colon tissues. We also examined the expression of iNOS by 
immunohistochemistry. To evaluate the proliferating activity of colonic epithelial cells and 
their response to DNA damage, we also examined the expression of p53 in the colon tissues. 
In theCD45RBhighCD4+Tcell-transferred mouse, significant 8-nitroguanine accumulation was 
induced in the nuclei and the cytoplasm of epithelial cells, and was also present in 
infiltrated cells supposed to be inflammatory cells in lamina propria. 8-Nitroguanine was 
formed in most of 8-oxodG-immunoreactive nuclei of epithelial cells and infiltrated cells 
(Fig. 8). When the sections were pretreated with RNase, 8-nitroguanine immunoreactivity 
was more clearly observed in the nuclei of epithelial cells (Ding et al., 2005). This result 
suggests that 8-nitroguanine was formed in genomic DNA. iNOS was expressed in the 
cytoplasm of epithelial cells and infiltrated cells in the lamina propria of the IBD mouse 
model (Fig. 8). iNOS was expressed mainly in 8-nitroguanine immunoreactive epithelial 
cells (Fig. 8). However, no or little 8-nitroguanine, 8-oxodG and iNOS were observed in non-
treated control mice. In the IBD mouse model, significant p53 was accumulated in the nuclei 
of regenerated epithelial cells. P53 was also expressed in some infiltrated cells. P53 
expression was overlapped with 8-nitroguanine (Fig. 8). The mice of IBD model that we 
used by transfer of CD45RBhighCD4+ T cells showed the similar results of histopathological 
analysis and immunohistochemical staining. No or little expression of p53 was observed in 
non-treated control mice. 
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Fig. 8. Formation of 8-nitroguanine, 8-oxodG, iNOS and p53 in the mouse model of 
inflammatory bowel disease. 8-Nitroguanine is accumulated in the nuclei and the cytoplasm 
of epithelial cells. 8-Nitroguanine is also present in infiltrated cells. 8-oxodG formation is 
observed in the nuclei of epithelial cells and the infiltrated cells in lamina propria, 8-oxodG 
and 8-nitroguanine co-localized in the nuclei of most epithelial cells and infiltrated cells, 
iNOS is expressed in the cytoplasm of epithelial cells and infiltrated cells in lamina propria, 
and iNOS and 8-nitroguanine colocalized in the cytoplasm of many epithelial cells and some 
infiltrated cells. Double immunostaining for 8-nitroguanine and p53, significant p53 
expression is observed in the nuclei of regenerated epithelial cells and some infiltrated cells. 
P53 is also induced in the cytoplasm of many epithelial cells in lower portions of the gland. 
P53 is expressed in most of 8-nitroguanine-immunoreactive epithelial cells. Scale bar 
represents 50 m. 
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4. Concluding 
We have investigated the mechanisms of oxidative and nitrative DNA damage induced by 
various inflammatory conditions. In relation to inflammation-related carcinogenesis, we 
examined the formation of 8-nitroguanine and 8-oxodG in human samples and animals. It is 
noteworthy that DNA damage was specifically induced at sites of carcinogenesis under 
various inflammatory conditions. In human samples, 8-nitroguanine formation was 
observed in gastric gland epithelial cells of patients with H. pylori infection (Ma et al., 2004) 
and in hepatocytes of patients with chronic hepatitis C (Horiike et al., 2005). 8-Nitroguanine 
was also formed in oral epithelium of OLP and OSCC patients (Chaiyarit et al., 2005; Ma et 
al., 2006). Moreover, in hamsters infected with the liver fluke Opisthorchis viverrini causing 
cholangiocarcinoma, 8-nitroguanine formation was induced in bile duct epithelium (Pinlaor 
et al., 2004b). 8-Nitroguanine formation was also found in colonic gland epithelial cells of 
mouse model of IBD (Ding et al., 2005). Therefore, 8-nitroguanine could be used as a 
potential biomarker to evaluate the risk of inflammation-related carcinogenesis. Recently, 8-
nitroguanosine has been reported to be a highly redox-active molecule that strongly 
stimulates O2-generation from NADPH-dependent reductases (Sawa et al., 2003). 8-
Nitroguaninemay be a cofactor for redox reaction and cell signaling implicated in diverse 
physiological and pathological events (Zaki et al., 2005). More importantly, experimental 
evidence has suggested that 8-nitroguanine is a mutagenic DNA lesion, which preferentially 
leads to G:C-to-T:A transversions (Yermilov et al., 1995b; Suzuki et al., 2005), in addition to 
8-oxodG (Shibutani et al., 1991; Bruner et al., 2000). Indeed, G:C-to-T:A transversions have 
been observed in vivo in the ras gene (Bos, 1988) and the p53 tumor suppressor gene in lung 
and liver cancer (Takahashi et al., 1989; Prahalad et al., 1999). We also investigated the role 
of DNA damage in carcinogenesis initiated by K-ras mutation, using conditional transgenic 
mice. Immunohistochemical analysis revealed that mutagenic 8-nitroguanine and 8-oxodG 
were apparently formed in adenocarcinoma caused by mutated K-ras. 8-Nitroguanine was 
co-localized with iNOS, NF-B, IKK, MAPK, MEK, and mutated K-ras, suggesting that 
oncogenic K-ras causes additional DNA damage via signaling pathway involving these 
molecules. It is noteworthy that K-ras mutation mediates not only cell over-proliferation but 
also the accumulation of mutagenic DNA lesions, leading to carcinogenesis (Ohnishi et al., 
2011). These findings imply that DNA damage mediated by ROS and RNS may participate 
in carcinogenesis via activation of protooncogenes and inactivation of tumor suppressor 
genes. In conclusion, oxidative and nitrative DNA damage could be promising biomarkers 
to evaluate the risk of carcinogenesis induced by a wide variety of chemicals and 
inflammatory conditions. 
5. Acknowledgments and funding 
This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, 
Science and Technology of Japan and Otsuka Pharmaceutical Co., Ltd. Japan. 
6. References 
Aggarwal, B. B. and Sung B. (2011). The relationship between inflammation and cancer is 
analogous to that between fuel and fire. Oncology (Williston Park), Vol.25, No.5 (Apr 
30), pp. (414-418), 0890-9091 (Print) 
www.intechopen.com
8-Nitroguanine, a Potential Biomarker to 
Evaluate the Risk of Inflammation-Related Carcinogenesis 
 
219 
Akaike, T., Okamoto S., Sawa T., Yoshitake J., Tamura F., Ichimori K., Miyazaki K., 
Sasamoto K. and Maeda H. (2003). 8-Nitroguanosine formation in viral pneumonia 
and its implication for pathogenesis. Proc Natl Acad Sci U S A, Vol.100, No.2 (Jan 
21), pp. (685-690), 0027-8424 (Print) 
Altorki, N. K., Subbaramaiah K. and Dannenberg A. J. (2004). COX-2 inhibition in upper 
aerodigestive tract tumors. Semin Oncol, Vol.31, No.2 Suppl 7 (Apr), pp. (30-36), 
0093-7754 (Print) 
Baik, S. C., Youn H. S., Chung M. H., Lee W. K., Cho M. J., Ko G. H., Park C. K., Kasai H. 
and Rhee K. H. (1996). Increased oxidative DNA damage in Helicobacter pylori-
infected human gastric mucosa. Cancer Res, Vol.56, No.6 (Mar 15), pp. (1279-1282), 
0008-5472 (Print) 
Balkwill, F. and Mantovani A. (2001). Inflammation and cancer: back to Virchow? Lancet, 
Vol.357, No.9255 (Feb 17), pp. (539-545). 
Bos, J. L. (1988). Ras oncogenes in hematopoietic malignancies. Hematol Pathol, Vol.2, No.2 
pp. (55-63), 0886-0238 (Print) 
Bouma, G. and Strober W. (2003). The immunological and genetic basis of inflammatory 
bowel disease. Nat Rev Immunol, Vol.3, No.7 (Jul), pp. (521-533), 1474-1733 (Print) 
Bruner, S. D., Norman D. P. and Verdine G. L. (2000). Structural basis for recognition and 
repair of the endogenous mutagen 8-oxoguanine in DNA. Nature, Vol.403, No.6772 
(Feb 24), pp. (859-866), 0028-0836 (Print) 
Chaiyarit, P., Ma N., Hiraku Y., Pinlaor S., Yongvanit P., Jintakanon D., Murata M., Oikawa 
S. and Kawanishi S. (2005). Nitrative and oxidative DNA damage in oral lichen 
planus in relation to human oral carcinogenesis. Cancer Sci, Vol.96, No.9 (Sep), pp. 
(553-559), 1347-9032 (Print) 
Chen, H., Hutt-Fletcher L., Cao L. and Hayward S. D. (2003). A positive autoregulatory loop 
of LMP1 expression and STAT activation in epithelial cells latently infected with 
Epstein-Barr virus. J Virol, Vol.77, No.7 (Apr), pp. (4139-4148), 0022-538X (Print) 
Choi, P. M. and Zelig M. P. (1994). Similarity of colorectal cancer in Crohn's disease and 
ulcerative colitis: implications for carcinogenesis and prevention. Gut, Vol.35, No.7 
(Jul), pp. (950-954), 0017-5749 (Print) 
Coussens, L. M. and Werb Z. (2002). Inflammation and cancer. Nature, Vol.420, No.6917 (Dec 
19-26), pp. (860-867). 
Dekker, N. P., Lozada-Nur F., Lagenaur L. A., MacPhail L. A., Bloom C. Y. and Regezi J. A. 
(1997). Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med, 
Vol.26, No.4 (Apr), pp. (170-175), 0904-2512 (Print) 
Ding, X., Hiraku Y., Ma N., Kato T., Saito K., Nagahama M., Semba R., Kuribayashi K. and 
Kawanishi S. (2005). Inducible nitric oxide synthase-dependent DNA damage in 
mouse model of inflammatory bowel disease. Cancer Sci, Vol.96, No.3 (Mar), pp. 
(157-163), 1347-9032 (Print) 
Ekbom, A., Helmick C., Zack M. and Adami H. O. (1990). Increased risk of large-bowel 
cancer in Crohn's disease with colonic involvement. Lancet, Vol.336, No.8711 (Aug 
11), pp. (357-359), 0140-6736 (Print) 
Enwonwu, C. O. and Meeks V. I. (1995). Bionutrition and oral cancer in humans. Crit Rev 
Oral Biol Med, Vol.6, No.1 pp. (5-17), 1045-4411 (Print) 
Fujita, N., Sugimoto R., Ma N., Tanaka H., Iwasa M., Kobayashi Y., Kawanishi S., Watanabe 
S., Kaito M. and Takei Y. (2008). Comparison of hepatic oxidative DNA damage in 
www.intechopen.com
 
Biomarker 
 
220 
patients with chronic hepatitis B and C. J Viral Hepat, Vol.15, No.7 (Jul), pp. (498-
507), 1365-2893 (Electronic) 
Hofseth, L. J., Khan M. A., Ambrose M., Nikolayeva O., Xu-Welliver M., Kartalou M., 
Hussain S. P., Roth R. B., Zhou X., Mechanic L. E., Zurer I., Rotter V., Samson L. D. 
and Harris C. C. (2003a). The adaptive imbalance in base excision-repair enzymes 
generates microsatellite instability in chronic inflammation. J Clin Invest, Vol.112, 
No.12 (Dec), pp. (1887-1894), 0021-9738 (Print) 
Hofseth, L. J., Saito S., Hussain S. P., Espey M. G., Miranda K. M., Araki Y., Jhappan C., 
Higashimoto Y., He P., Linke S. P., Quezado M. M., Zurer I., Rotter V., Wink D. A., 
Appella E. and Harris C. C. (2003b). Nitric oxide-induced cellular stress and p53 
activation in chronic inflammation. Proc Natl Acad Sci U S A, Vol.100, No.1 (Jan 7), 
pp. (143-148), 0027-8424 (Print) 
Hoki, Y., Hiraku Y., Ma N., Murata M., Matsumine A., Nagahama M., Shintani K., Uchida 
A. and Kawanishi S. (2007a). iNOS-dependent DNA damage in patients with 
malignant fibrous histiocytoma in relation to prognosis. Cancer Sci, Vol.98, No.2 
(Feb), pp. (163-168), 1347-9032 (Print) 
Hoki, Y., Murata M., Hiraku Y., Ma N., Matsumine A., Uchida A. and Kawanishi S. (2007b). 
8-Nitroguanine as a potential biomarker for progression of malignant fibrous 
histiocytoma, a model of inflammation-related cancer. Oncol Rep, Vol.18, No.5 
(Nov), pp. (1165-1169), 1021-335X (Print) 
Horiike, S., Kawanishi S., Kaito M., Ma N., Tanaka H., Fujita N., Iwasa M., Kobayashi Y., 
Hiraku Y., Oikawa S., Murata M., Wang J., Semba R., Watanabe S. and Adachi Y. 
(2005). Accumulation of 8-nitroguanine in the liver of patients with chronic 
hepatitis C. J Hepatol, Vol.43, No.3 (Sep), pp. (403-410), 0168-8278 (Print) 
Huang, Y. J., Zhang B. B., Ma N., Murata M., Tang A. Z. and Huang G. W. (2011). Nitrative 
and oxidative DNA damage as potential survival biomarkers for nasopharyngeal 
carcinoma. Med Oncol, Vol.28, No.1 (Mar), pp. (377-384), 1559-131X (Electronic) 
Hussain, S. P. and Harris C. C. (2007). Inflammation and cancer: an ancient link with novel 
potentials. Int. J. Cancer, Vol.121, No.11 (Dec 1), pp. (2373-2380),  
Hussain, S. P., Hofseth L. J. and Harris C. C. (2003). Radical causes of cancer. Nat Rev Cancer, 
Vol.3, No.4 (Apr), pp. (276-285), 1474-175X (Print) 
Kamp, D. W., Shacter E. and Weitzman S. A. (2011). Chronic inflammation and cancer: the 
role of the mitochondria. Oncology (Williston Park), Vol.25, No.5 (Apr 30), pp. (400-
410, 413), 0890-9091 (Print) 
Kawanishi, S. and Hiraku Y. (2006). Oxidative and nitrative DNA damage as biomarker for 
carcinogenesis with special reference to inflammation. Antioxid Redox Signal, Vol.8, 
No.5-6 (May-Jun), pp. (1047-1058), 1523-0864 (Print) 
Kawanishi, S., Hiraku Y., Murata M. and Oikawa S. (2002). The role of metals in site-specific 
DNA damage with reference to carcinogenesis. Free Radic Biol Med, Vol.32, No.9 
(May 1), pp. (822-832), 0891-5849 (Print) 
Kawanishi, S., Hiraku Y. and Oikawa S. (2001). Mechanism of guanine-specific DNA 
damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res, 
Vol.488, No.1 (Mar), pp. (65-76), 0027-5107 (Print) 
Kawanishi, S., Hiraku Y., Pinlaor S. and Ma N. (2006). Oxidative and nitrative DNA damage 
in animals and patients with inflammatory diseases in relation to inflammation-
related carcinogenesis. Biol Chem, Vol.387, No.4 (Apr), pp. (365-372), 1431-6730 
(Print) 
www.intechopen.com
8-Nitroguanine, a Potential Biomarker to 
Evaluate the Risk of Inflammation-Related Carcinogenesis 
 
221 
Kawanishi, S. and Murata M. (2006). Mechanism of DNA damage induced by bromate 
differs from general types of oxidative stress. Toxicology, Vol.221, No.2-3 (Apr 17), 
pp. (172-178), 0300-483X (Print) 
Langholz, E., Munkholm P., Davidsen M. and Binder V. (1992). Colorectal cancer risk and 
mortality in patients with ulcerative colitis. Gastroenterology, Vol.103, No.5 (Nov), 
pp. (1444-1451), 0016-5085 (Print) 
Lo, H. W., Hsu S. C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., Bartholomeusz G., Shih J. Y. 
and Hung M. C. (2005). Nuclear interaction of EGFR and STAT3 in the activation of 
the iNOS/NO pathway. Cancer Cell, Vol.7, No.6 (Jun), pp. (575-589), 1535-6108 
(Print) 
Loeb, L. A. and Preston B. D. (1986). Mutagenesis by apurinic/apyrimidinic sites. Annu Rev 
Genet, Vol.20, pp. (201-230), 0066-4197 (Print) 
Lumerman, H., Freedman P. and Kerpel S. (1995). Oral epithelial dysplasia and the 
development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 
Oral Radiol Endod, Vol.79, No.3 (Mar), pp. (321-329), 1079-2104 (Print) 
Ma, N., Adachi Y., Hiraku Y., Horiki N., Horiike S., Imoto I., Pinlaor S., Murata M., Semba R. 
and Kawanishi S. (2004). Accumulation of 8-nitroguanine in human gastric 
epithelium induced by Helicobacter pylori infection. Biochem Biophys Res Commun, 
Vol.319, No.2 (Jun 25), pp. (506-510), 0006-291X (Print) 
Ma, N., Kawanishi M., Hiraku Y., Murata M., Huang G. W., Huang Y., Luo D. Z., Mo W. G., 
Fukui Y. and Kawanishi S. (2008). Reactive nitrogen species-dependent DNA 
damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 
activation and EGFR expression. Int J Cancer, Vol.122, No.11 (Jun 1), pp. (2517-
2525), 1097-0215 (Electronic) 
Ma, N., Sasaki T., Sakata-Haga H., Ohta K., Gao M., Kawanishi S. and Fukui Y. (2009). 
Protective effect of taurine against nitrosative stress in the stomach of rat with 
water immersion restraint stress. Adv Exp Med Biol, Vol.643, pp. (273-283), 0065-
2598 (Print) 
Ma, N., Sasoh M., Kawanishi S., Sugiura H. and Piao F. (2010). Protection effect of taurine on 
nitrosative stress in the mice brain with chronic exposure to arsenic. J Biomed Sci, 
Vol.17 Suppl 1, pp. (S7), 1423-0127 (Electronic) 
Ma, N., Tagawa T., Hiraku Y., Murata M., Ding X. and Kawanishi S. (2006). 8-Nitroguanine 
formation in oral leukoplakia, a premalignant lesion. Nitric Oxide, Vol.14, No.2 
(Mar), pp. (137-143), 1089-8603 (Print) 
Ma, N., Thanan R., Kobayashi H., Hammam O., Wishahi M., Leithy T. E., Hiraku Y., Amro 
E. K., Oikawa S., Ohnishi S., Murata M. and Kawanishi S. (2011). Nitrative DNA 
damage and Oct3/4 expression in urinary bladder cancer with 
Schistosomahaematobium infection. Biochem Biophys Res Commun, (Sep 17), pp. 
1090-2104 (Electronic) 
Maeda, H. and Akaike T. (1998). Nitric oxide and oxygen radicals in infection, inflammation, 
and cancer. Biochemistry (Mosc), Vol.63, No.7 (Jul), pp. (854-865), 0006-2979 (Print) 
Maeda, S., Akanuma M., Mitsuno Y., Hirata Y., Ogura K., Yoshida H., Shiratori Y. and 
Omata M. (2001). Distinct mechanism of Helicobacter pylori-mediated NF-kappa B 
activation between gastric cancer cells and monocytic cells. J Biol Chem, Vol.276, 
No.48 (Nov 30), pp. (44856-44864), 0021-9258 (Print) 
Mannick, E. E., Bravo L. E., Zarama G., Realpe J. L., Zhang X. J., Ruiz B., Fontham E. T., 
Mera R., Miller M. J. and Correa P. (1996). Inducible nitric oxide synthase, 
www.intechopen.com
 
Biomarker 
 
222 
nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and 
antioxidants. Cancer Res, Vol.56, No.14 (Jul 15), pp. (3238-3243), 0008-5472 (Print) 
McDermott, A. L., Dutt S. N. and Watkinson J. C. (2001). The aetiology of nasopharyngeal 
carcinoma. Clin Otolaryngol Allied Sci, Vol.26, No.2 (Apr), pp. (82-92), 0307-7772 
(Print) 
Mignogna, M. D., Fedele S., Lo Russo L., Lo Muzio L. and Bucci E. (2004). Immune 
activation and chronic inflammation as the cause of malignancy in oral lichen 
planus: is there any evidence ? Oral Oncol, Vol.40, No.2 (Feb), pp. (120-130), 1368-
8375 (Print) 
Neville, B. W. and Day T. A. (2002). Oral cancer and precancerous lesions. CA Cancer J Clin, 
Vol.52, No.4 (Jul-Aug), pp. (195-215), 0007-9235 (Print) 
Ohnishi, S., Saito H., Suzuki N., Ma N., Hiraku Y., Murata M. and Kawanishi S. (2011). 
Nitrative and oxidative DNA damage caused by K-ras mutation in mice. Biochem 
Biophys Res Commun, Vol.413, No.2 (Sep 23), pp. (236-240), 1090-2104 (Electronic) 
Ohshima, H., Tatemichi M. and Sawa T. (2003). Chemical basis of inflammation-induced 
carcinogenesis. Arch Biochem Biophys, Vol.417, No.1 (Sep 1), pp. (3-11), 0003-9861 
(Print) 0003-9861 (Linking) 
Peek, R. M., Jr. and Blaser M. J. (2002). Helicobacter pylori and gastrointestinal tract 
adenocarcinomas. Nat Rev Cancer, Vol.2, No.1 (Jan), pp. (28-37), 1474-175X (Print) 
Philippe, D., Dubuquoy L., Groux H., Brun V., Chuoi-Mariot M. T., Gaveriaux-Ruff C., 
Colombel J. F., Kieffer B. L. and Desreumaux P. (2003). Anti-inflammatory 
properties of the mu opioid receptor support its use in the treatment of colon 
inflammation. J Clin Invest, Vol.111, No.9 (May), pp. (1329-1338), 0021-9738 (Print) 
Pignatelli, B., Bancel B., Plummer M., Toyokuni S., Patricot L. M. and Ohshima H. (2001). 
Helicobacter pylori eradication attenuates oxidative stress in human gastric 
mucosa. Am J Gastroenterol, Vol.96, No.6 (Jun), pp. (1758-1766), 0002-9270 (Print) 
Pikarsky, E., Porat R. M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., 
Urieli-Shoval S., Galun E. and Ben-Neriah Y. (2004). NF-kappaB functions as a 
tumour promoter in inflammation-associated cancer. Nature, Vol.431, No.7007 (Sep 
23), pp. (461-466), 1476-4687 (Electronic) 
Pinlaor, S., Hiraku Y., Ma N., Yongvanit P., Semba R., Oikawa S., Murata M., Sripa B., 
Sithithaworn P. and Kawanishi S. (2004a). Mechanism of NO-mediated oxidative 
and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a 
model of inflammation-mediated carcinogenesis. Nitric Oxide, Vol.11, No.2 (Sep), 
pp. (175-183), 1089-8603 (Print) 
Pinlaor, S., Hiraku Y., Yongvanit P., Tada-Oikawa S., Ma N., Pinlaor P., Sithithaworn P., 
Sripa B., Murata M., Oikawa S. and Kawanishi S. (2006). iNOS-dependent DNA 
damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini 
and its suppression by the antihelminthic drug praziquantel. Int J Cancer, Vol.119, 
No.5 (Sep 1), pp. (1067-1072), 0020-7136 (Print) 
Pinlaor, S., Ma N., Hiraku Y., Yongvanit P., Semba R., Oikawa S., Murata M., Sripa B., 
Sithithaworn P. and Kawanishi S. (2004b). Repeated infection with Opisthorchis 
viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-
deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. 
Carcinogenesis, Vol.25, No.8 (Aug), pp. (1535-1542), 0143-3334 (Print) 
Pinlaor, S., Yongvanit P., Hiraku Y., Ma N., Semba R., Oikawa S., Murata M., Sripa B., 
Sithithaworn P. and Kawanishi S. (2003). 8-Nitroguanine formation in the liver of 
www.intechopen.com
8-Nitroguanine, a Potential Biomarker to 
Evaluate the Risk of Inflammation-Related Carcinogenesis 
 
223 
hamsters infected with Opisthorchis viverrini. Biochem Biophys Res Commun, 
Vol.309, No.3 (Sep 26), pp. (567-571), 0006-291X (Print) 
Podolsky, D. K. (2002). Inflammatory bowel disease. N Engl J Med, Vol.347, No.6 (Aug 8), 
pp. (417-429), 1533-4406 (Electronic) 
Powrie, F., Leach M. W., Mauze S., Caddle L. B. and Coffman R. L. (1993). Phenotypically 
distinct subsets of CD4+ T cells induce or protect from chronic intestinal 
inflammation in C. B-17 scid mice. Int Immunol, Vol.5, No.11 (Nov), pp. (1461-1471), 
0953-8178 (Print) 
Prahalad, A. K., Manchester D. K., Hsu I. C., Inmon J. and Gallagher J. E. (1999). Human 
placental microsomal activation and DNA adduction by air pollutants. Bull Environ 
Contam Toxicol, Vol.62, No.1 (Jan), pp. (93-100), 0007-4861 (Print) 
Rajentheran, R., McLean N. R., Kelly C. G., Reed M. F. and Nolan A. (1999). Malignant 
transformation of oral lichen planus. Eur J Surg Oncol, Vol.25, No.5 (Oct), pp. (520-
523), 0748-7983 (Print) 
Reibel, J. (2003). Prognosis of oral pre-malignant lesions: significance of clinical, 
histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med, 
Vol.14, No.1 pp. (47-62), 1544-1113 (Electronic) 
Renkonen, J., Wolff H. and Paavonen T. (2002). Expression of cyclo-oxygenase-2 in human 
tongue carcinoma and its precursor lesions. Virchows Arch, Vol.440, No.6 (Jun), pp. 
(594-597), 0945-6317 (Print) 
Rodriguez-Perez, I. and Banoczy J. (1982). Oral leukoplakia. A histopathological study. Acta 
Morphol Acad Sci Hung, Vol.30, No.3-4 pp. (289-298), 0001-6217 (Print) 
Rook, G. A. and Dalgleish A. (2011). Infection, immunoregulation, and cancer. Immunol Rev, 
Vol.240, No.1 (Mar), pp. (141-159), 1600-065X (Electronic) 
Sawa, T., Akaike T., Ichimori K., Akuta T., Kaneko K., Nakayama H., Stuehr D. J. and Maeda 
H. (2003). Superoxide generation mediated by 8-nitroguanosine, a highly redox-
active nucleic acid derivative. Biochem Biophys Res Commun, Vol.311, No.2 (Nov 14), 
pp. (300-306), 0006-291X (Print) 
Schetter, A. J., Heegaard N. H. and Harris C. C. (2010). Inflammation and cancer: 
interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis, 
Vol.31, No.1 (Jan), pp. (37-49), 1460-2180 (Electronic) 
Scully, C., Beyli M., Ferreiro M. C., Ficarra G., Gill Y., Griffiths M., Holmstrup P., Mutlu S., 
Porter S. and Wray D. (1998). Update on oral lichen planus: etiopathogenesis and 
management. Crit Rev Oral Biol Med, Vol.9, No.1 pp. (86-122), 1045-4411 (Print) 
Shibutani, S., Takeshita M. and Grollman A. P. (1991). Insertion of specific bases during 
DNA synthesis past the oxidation-damaged base 8-oxodG. Nature, Vol.349, No.6308 
(Jan 31), pp. (431-434), 0028-0836 (Print) 
Suarez, P., Batsakis J. G. and el-Naggar A. K. (1998). Leukoplakia: still a gallimaufry or is 
progress being made?--A review. Adv Anat Pathol, Vol.5, No.3 (May), pp. (137-155), 
1072-4109 (Print) 1072-4109 (Linking) 
Sudbo, J. and Reith A. (2005). The evolution of predictive oncology and molecular-based 
therapy for oral cancer prevention. Int J Cancer, Vol.115, No.3 (Jun 20), pp. (339-
345), 0020-7136 (Print) 
Surh, Y. J., Chun K. S., Cha H. H., Han S. S., Keum Y. S., Park K. K. and Lee S. S. (2001). 
Molecular mechanisms underlying chemopreventive activities of anti-
inflammatory phytochemicals: down-regulation of COX-2 and iNOS through 
www.intechopen.com
 
Biomarker 
 
224 
suppression of NF-kappa B activation. Mutat Res, Vol.480-481, (Sep 1), pp. (243-
268), 0027-5107 (Print) 
Suzuki, N., Yasui M., Geacintov N. E., Shafirovich V. and Shibutani S. (2005). Miscoding 
events during DNA synthesis past the nitration-damaged base 8-nitroguanine. 
Biochemistry, Vol.44, No.25 (Jun 28), pp. (9238-9245), 0006-2960 (Print) 
Takahashi, T., Nau M. M., Chiba I., Birrer M. J., Rosenberg R. K., Vinocour M., Levitt M., 
Pass H., Gazdar A. F. and Minna J. D. (1989). p53: a frequent target for genetic 
abnormalities in lung cancer. Science, Vol.246, No.4929 (Oct 27), pp. (491-494), 0036-
8075 (Print) 
Tanaka, H., Fujita N., Sugimoto R., Urawa N., Horiike S., Kobayashi Y., Iwasa M., Ma N., 
Kawanishi S., Watanabe S., Kaito M. and Takei Y. (2008). Hepatic oxidative DNA 
damage is associated with increased risk for hepatocellular carcinoma in chronic 
hepatitis C. Br J Cancer, Vol.98, No.3 (Feb 12), pp. (580-586), 0007-0920 (Print) 
Tao, Y., Song X., Deng X., Xie D., Lee L. M., Liu Y., Li W., Li L., Deng L., Wu Q., Gong J. and 
Cao Y. (2005). Nuclear accumulation of epidermal growth factor receptor and 
acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane 
protein 1. Exp Cell Res, Vol.303, No.2 (Feb 15), pp. (240-251), 0014-4827 (Print) 
Tedeschi, E., Menegazzi M., Margotto D., Suzuki H., Forstermann U. and Kleinert H. (2003). 
Anti-inflammatory actions of St. John's wort: inhibition of human inducible nitric-
oxide synthase expression by down-regulating signal transducer and activator of 
transcription-1alpha (STAT-1alpha) activation. J Pharmacol Exp Ther, Vol.307, No.1 
(Oct), pp. (254-261), 0022-3565 (Print) 
Trinchieri, G. (2011). Inflammation in cancer: a therapeutic target? Oncology (Williston Park), 
Vol.25, No.5 (Apr 30), pp. (418-420), 0890-9091 (Print) 
Tyldesley, W. R. and Appleton J. (1973). Observations on the ultrastructure of the 
epithelium in oral lichen planus. J Oral Pathol, Vol.2, No.1 pp. (46-57), 0300-9777 
(Print) 
Yermilov, V., Rubio J., Becchi M., Friesen M. D., Pignatelli B. and Ohshima H. (1995a). 
Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. 
Carcinogenesis, Vol.16, No.9 (Sep), pp. (2045-2050), 0143-3334 (Print) 
Yermilov, V., Rubio J. and Ohshima H. (1995b). Formation of 8-nitroguanine in DNA treated 
with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS 
Lett, Vol.376, No.3 (Dec 4), pp. (207-210), 0014-5793 (Print) 
Yu, J. S., Tsai H. C., Wu C. C., Weng L. P., Li H. P., Chung P. J. and Chang Y. S. (2002). 
Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived 
LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-
mediated transformation. Oncogene, Vol.21, No.52 (Nov 14), pp. (8047-8061), 0950-
9232 (Print) 
Zaki, M. H., Akuta T. and Akaike T. (2005). Nitric oxide-induced nitrative stress involved in 
microbial pathogenesis. J Pharmacol Sci, Vol.98, No.2 (Jun), pp. (117-129), 1347-8613 
(Print) 
www.intechopen.com
Biomarker
Edited by Prof. Tapan Khan
ISBN 978-953-51-0577-0
Hard cover, 392 pages
Publisher InTech
Published online 27, April, 2012
Published in print edition April, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Clinicians, scientists, and health care professionals use biomarkers or biological markers as a measure of a
person’s present health condition or response to interventions. An ideal -biomarker should have the following
criteria: (I) ability to detect fundamental features of the disease, (II) ability to differentiate from other closely
related diseases, (III) ability to detect early stages and stages of progression, (IV) the method should be highly
reliable, easy to perform and inexpensive, and (V) sample sources should be easily accessible from body.
Most of the chapters in this book follow the basic principle of biomarkers.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ning Ma, Mariko Murata, Shiho Ohnishi, Raynoo Thanan, Yusuke Hiraku and Shosuke Kawanishi (2012). 8-
Nitroguanine, a Potential Biomarker to Evaluate the Risk of Inflammation-Related Carcinogenesis, Biomarker,
Prof. Tapan Khan (Ed.), ISBN: 978-953-51-0577-0, InTech, Available from:
http://www.intechopen.com/books/biomarker/8-nitroguanine-a-potential-biomarker-to-evaluate-the-risk-of-
inflammation-related-carcinogenesis
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
